×
| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 17 Nov 2025 | Choice Institutional Equities | Buy | ₹795.4 | ₹1,050 | 32.3% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| YATHARTH HOSPITAL & TRAUMA CAR | 2889.1 | 412.53 | 2794.21 | 4.28 | 7,529 | 52.9 |
| STRIDES PHARMA SCIENCE LIMITED | 12,479.71 | 1,315.24 | 12,208.31 | 13.84 | 7517 | 20.1 |
| Aarti Pharmalabs Limited | 4,183.85 | 279.23 | 4,183.35 | 3.08 | 7469 | 28.0 |
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED, with Security Code 543950, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 110.1 | 101.7 | 105.6 | 119.0 | 112.9 | 110.4 | 112.0 | 130.1 |
| Expenses | 78.8 | 72.4 | 78.0 | 86.2 | 82.2 | 78.6 | 80.1 | 95.1 |
| Operating Profit | 31.3 | 29.3 | 27.6 | 32.8 | 30.7 | 31.8 | 31.9 | 35.1 |
| OPM % | 28.42% | 28.83% | 26.13% | 27.56% | 27.16% | 28.8% | 28.44% | 26.93% |
| Other Income | 3.3 | 4.8 | 5.1 | 2.6 | 1.8 | 3.2 | 4.1 | 7.3 |
| Interest | 1.6 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 |
| Depreciation | 3.2 | 4.0 | 3.1 | 4.0 | 4.8 | 5.2 | 4.7 | 4.7 |
| Profit before tax | 29.9 | 30.0 | 29.3 | 31.3 | 27.5 | 29.6 | 31.1 | 37.5 |
| Tax % | -29.6% | -29.6% | -10.5% | -26.1% | 25.8% | -24.9% | -29.3% | 27.6% |
| Net Profit | 21.0 | 21.1 | 26.2 | 23.1 | 20.4 | 22.3 | 21.9 | 27.1 |
| EPS in Rs | 2.9 | 2.74 | 3.32 | 2.7 | 2.37 | 2.6 | 0 | 2.81 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 171.3 | 166.8 | 177.8 | 211.8 | 217.8 | 219.2 | 231.8 | 279.4 |
| Expenses | 125.7 | 120.4 | 131.2 | 158.1 | 163.1 | 164.2 | 174.7 | 214.9 |
| Operating Profit | 45.6 | 46.4 | 46.5 | 53.7 | 54.6 | 54.9 | 57.1 | 64.5 |
| OPM % | 26.61% | 27.83% | 26.18% | 25.34% | 25.09% | 25.06% | 24.65% | 23.09% |
| Other Income | 3.8 | 5.4 | 5.7 | 3.7 | 3.0 | 4.2 | 5.3 | 9.5 |
| Interest | 2.9 | 0.2 | 0.4 | 2.9 | 1.6 | 2.1 | 1.0 | 0.3 |
| Depreciation | 6.9 | 7.9 | 7.7 | 11.4 | 15.9 | 16.9 | 12.9 | 18.9 |
| Profit before tax | 39.6 | 43.8 | 44.1 | 43.0 | 40.1 | 40.2 | 48.6 | 54.8 |
| Tax % | -30.2% | -32.6% | -13.1% | 29.3% | -22.8% | 24.1% | -20.2% | 24.8% |
| Net Profit | 27.6 | 29.5 | 38.3 | 30.4 | 31.0 | 30.5 | 38.7 | 41.3 |
| EPS in Rs | 3.8 | 3.83 | 4.85 | 3.54 | 3.59 | 3.57 | 0 | 4.28 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 34% |
| 3 Years: | 34% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 96% |
| 3 Years: | 90% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 47% |
| 3 Years: | 43% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 96% |
| 3 Years: | 85% |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|